Pharmafile Logo
Pharmafocus logo
Advanced Search

Gilead

Showing 15 posts of 244 posts found.

Harvoni image

NICE recommends Harvoni for hepatitis C

March 3, 2015
Sales and Marketing Gilead, NICE, harvoni, hepatitis C, ledipasvir-sofosbuvir

NICE has signalled a provisional OK for Gilead’s Harvoni to be used as a treatment for hepatitis C by the …

News
Sovaldi image

Gilead frustrated despite final NICE Sovaldi nod

February 25, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, sofosbuvir, sovaldi

NICE has published final guidance confirming its approval of Gilead’s controversial blockbuster hepatitis C treatment Sovaldi – but Gilead and …

News
Isentress image

Merck puts HIV drug in shared patent pool

February 24, 2015
Research and Development, Sales and Marketing AbbVie, Gilead, HIV, Merck, Raltegravir, Roche, isentress

Merck is teaming up with the Medicines Patent Pool (MPP) to license its paediatric HIV treatment in developing countries. The …

News
Doctors image

Charity challenges Sovaldi patent

February 10, 2015
Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization

Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …

News
Gilead image

Gilead expands UK presence with new London HQ

February 10, 2015
Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge

Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …

News
FDA image

Pharma adverse event FDA reports are inadequate

February 5, 2015
Sales and Marketing FDA, Gilead, Solvaldi, US Institute for Safe Medication Practices, pharma, sofosbuvir

Reports of adverse drug events submitted to the FDA by pharma firms are often incomplete and lacking in detail, a …

News
Gilead image

Gilead sales soar on back of hepatitis drugs

February 4, 2015
Sales and Marketing Atripla, Gilead, efavirenz, emtricitabine, harvoni, lepidasvir, q4, sofosbuvir, sovaldi, tenofovi

The new blockbuster hepatitis C treatments Sovaldi and Harvoni more than doubled Gilead’s sales in the last quarter of 2014 …

News
BMS image

BMS wins FDA approval for HIV pill

January 30, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, FDA, Gilead, Reyataz, atazanavir, cobicistat), evotaz, tybost

Bristol-Myers Squibb has earned FDA approval for its HIV combination treatment Evotaz. The US drugs regulator gave BMS the go-ahead …

News
andrew_cheng

Gilead makes two senior promotions

January 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, andrew cheng

Gilead Sciences has promoted Dr Andrew Cheng to the position of executive vice president, HIV therapeutics and development operations, and …

Appointment
Gilead image

New drug added to generic Sovaldi licensing

January 26, 2015
Manufacturing and Production, Sales and Marketing Gilead, HCV, hepatitis C, sofosbuvir, sovaldi

Gilead has expanded the licensing of generic versions of its blockbuster hepatitis C treatment Sovaldi to include a new experimental …

News

Gilead and Strides partner in HIV

January 21, 2015
Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf

Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …

News
Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

News

Gilead acquires Phenex liver disease drugs

January 7, 2015
Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex

Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …

News
Abbvie

Abbvie Hep C drug gains FDA approval

December 22, 2014
Sales and Marketing AbbVie, FDA, Gilead, Viekira Pak, dasabuvir, harvoni, hepatitis, hepatits C

Abbvie has gained sign-off for its rival treatment to challenge Gilead’s dominance of the growing market for new hepatitis C …

News
Janssen image

Janssen launches HIV combination pill

December 17, 2014
Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025